Thursday, September 22, 2011
Health Canada lets Bayer resume sales of controversial clotting drug
TORONTO - A controversial clotting drug pulled from sale in Canada and abroad several years ago is being allowed back on the Canadian market. Health Canada announced Wednesday it is letting Bayer Inc....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment